Achieving lipid goals with rosuvastatin compared to simvastatin : DISCOVERY-beta studyLaks, Toivo; Keba, Ester; Leiner, Mariann; Merilind, Eero; Petersen, Mall; Reinmets, Sirje; Väli, Sille; Sööt, Terje; Otter, KarinCirculation : World Congress of Cardiology : Buenos Aires, 18-21 May, 20082008 / p. P302 https://pubmed.ncbi.nlm.nih.gov/19337553/

Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice : a randomized, open-label, parallel-group, multi-center study : the DISCOVERY-beta studyLaks, Toivo; Keba, Ester; Leiner, Mariann; Merilind, Eero; Petersen, Mall; Reinmets, Sirje; Väli, Sille; Sööt, Terje; Otter, KarinVascular health and risk management2008 / 6, p. 1147-1156 https://pubmed.ncbi.nlm.nih.gov/19337553/

Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemiaFerrari, Roberto; Aguiar, Carlos; Alegria, Eduardo; Viigimaa, MargusEuropean heart journal. Supplements : journal of the European Society of Cardiology2016 / p. C2-C12 : ill http://dx.doi.org/10.1093/eurheartj/suw009

Kolesteroolinäitudel tuleb silm peal hoidaMaasikamäe, SirjeTervis : teemaleht : [ajalehe Õhtuleht lisa]2022 / Lk. 6-7 https://dea.digar.ee/article/oltervis/2022/02/08/11

The role of red yeast rice (RYR) supplementation in plasma cholesterol control : a review and expert opinionBanach, Maciej; Bruckert, Eric; Descamps, Olivier S.; Viigimaa, MargusAtherosclerosis supplements2019 / p. e1−e8 : ill https://doi.org/10.1016/j.atherosclerosissup.2019.08.023